Skip to main content

Advertisement

SpringerLink
Log in

Managing atrial fibrillation: the need for an individualized approach even in the emergency department

  • IM - COMMENTARY
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Botto GL, Tortora G (2019) Is delayed cardioversion the better approach in recent-onset atrial fibrillation? Yes. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02225-x(this issue)

    Article  PubMed  Google Scholar 

  2. Capucci A, Compagnucci P (2019) Is delayed cardioversion the better approach in recent-onset atrial fibrillation? No. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02224-y(this issue)

    Article  PubMed  Google Scholar 

  3. Pluymaekers NAHA, Dudink EAMP, Luermans JGLM, Meeder JG, Lenderink T, Widdershoven J et al (2019) Early or delayed cardioversion in recent-onset atrial fibrillation. N Engl J Med. 380(16):1499–1508

    Article  Google Scholar 

  4. Boriani G, Diemberger I, Martignani C, Biffi M, Branzi A (2006) The epidemiological burden of atrial fibrillation: a challenge for clinicians and health care systems. Eur Heart J. 27(8):893–894

    Article  Google Scholar 

  5. Rozen G, Hosseini SM, Kaadan MI, Biton Y, Heist EK, Vangel M et al (2018) Emergency department visits for atrial fibrillation in the United States: trends in admission rates and economic burden from 2007 to 2014. J Am Heart Assoc 7(15):e009024

    Article  Google Scholar 

  6. Gilbert CJ, Angaran P, Mariano Z, Aves T, Dorian P (2018) Rhythm and rate control of atrial fibrillation in the emergency department - A large community-based observational study. CJEM. 20(6):834–840

    Article  Google Scholar 

  7. Gulizia MM, Cemin R, Colivicchi F, De Luca L, Di Lenarda A, Boriani G et al (2019) Management of atrial fibrillation in the emergency room and in the cardiology ward: the BLITZ AF study. Europace. 21(2):230–238

    Article  Google Scholar 

  8. Capucci A, Boriani G, Rubino I, Della Casa S, Sanguinetti M, Magnani B (1994) A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. Int J Cardiol. 43(3):305–313

    Article  CAS  Google Scholar 

  9. Boriani G, Biffi M, Capucci A, Botto GL, Broffoni T, Rubino I et al (1997) Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial. Ann Intern Med. 126(8):621–625

    Article  CAS  Google Scholar 

  10. Boriani G, Biffi M, Capucci A, Botto G, Broffoni T, Ongari M et al (1998) Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols. Pacing Clin Electrophysiol. 21(11 Pt 2):2470–2474

    Article  CAS  Google Scholar 

  11. Basso N, Giri S, Lezoche E, Materia A, Melchiorri P, Speranza V (1976) Effect of secretin, glucagon and duodenal acidification on bombesin-induced hypergastrinemia in man. Am J Gastroenterol. 66(5):448–451

    CAS  PubMed  Google Scholar 

  12. Dell'Orfano JT, Patel H, Wolbrette DL, Luck JC, Naccarelli GV (1999) Acute treatment of atrial fibrillation spontaneous conversion rates and cost of care. Am J Cardiol 83(5):788–790

    Article  CAS  Google Scholar 

  13. Boriani G, Martignani C, Biffi M, Capucci A, Branzi A (2002) Oral loading with propafenone for conversion of recent-onset atrial fibrillation: a review on in-hospital treatment. Drugs. 62(3):415–423

    Article  CAS  Google Scholar 

  14. Boriani G, Diemberger I, Biffi M, Martignani C, Branzi A (2004) Pharmacological cardioversion of atrial fibrillation: current management and treatment options. Drugs. 64(24):2741–2762

    Article  CAS  Google Scholar 

  15. Boriani G, Biffi M (2019) Early or delayed cardioversion in recent-onset atrial fibrillation. N Engl J Med. 381(4):385–386

    Article  Google Scholar 

  16. Danias PG, Caulfield TA, Weigner MJ, Silverman DI, Manning WJ (1998) Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm. J Am Coll Cardiol. 31(3):588–592

    Article  CAS  Google Scholar 

  17. Airaksinen KE, Grönberg T, Nuotio I, Nikkinen M, Ylitalo A, Biancari F et al (2013) Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study. J Am Coll Cardiol. 62(13):1187–1192

    Article  Google Scholar 

  18. January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC et al (2019) 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the american college of cardiology/american heart association task force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons. Circulation 140(2):e125–e151

    Article  Google Scholar 

  19. Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L et al (2018) The 2018 european heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 39(16):1330–1393

    Article  CAS  Google Scholar 

  20. Volterrani M, Iellamo F, Alberto C, Pasquale A, Salvatore P, Massimo P et al (2018) NOAC in "real world" patients with atrial fibrillation in Italy: results from the ISPAF-2 (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study. Intern Emerg Med. 13(7):1069–1075

    Article  Google Scholar 

  21. Malavasi VL, Pettorelli D, Fantecchi E, Zoccali C, Laronga G, Trenti T et al (2018) Variations in clinical management of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation according to different equations for estimating renal function : post hoc analysis of a prospective cohort. Intern Emerg Med. 13(7):1059–1067

    Article  Google Scholar 

  22. Tampieri A, Cipriano V, Mucci F, Rusconi AM, Lenzi T, Cenni P (2018) Safety of cardioversion in atrial fibrillation lasting less than 48 h without post-procedural anticoagulation in patients at low cardioembolic risk. Intern Emerg Med. 13(1):87–93

    Article  Google Scholar 

  23. Cristoni L, Tampieri A, Mucci F, Iannone P, Venturi A, Cavazza M et al (2011) Cardioversion of acute atrial fibrillation in the short observation unit: comparison of a protocol focused on electrical cardioversion with simple antiarrhythmic treatment. Emerg Med J. 28(11):932–937

    Article  Google Scholar 

  24. Boriani G, Maniadakis N, Auricchio A, Müller-Riemenschneider F, Fattore G, Leyva F et al (2013) Health technology assessment in interventional electrophysiology and device therapy: a position paper of the european heart rhythm association. Eur Heart J. 34(25):1869–1874

    Article  Google Scholar 

Download references

Funding

No funding was received for this work.

Author information

Authors and Affiliations

  1. Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy

    Giuseppe Boriani, Jacopo Francesco Imberti, Anna Chiara Valenti, Vincenzo Livio Malavasi & Marco Vitolo

Authors
  1. Giuseppe Boriani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacopo Francesco Imberti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anna Chiara Valenti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vincenzo Livio Malavasi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marco Vitolo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giuseppe Boriani.

Ethics declarations

Conflict of interest

Professor Boriani has received small speaker’s fees from Medtronic, Boston, Biotronik, Boehringer, and Bayer, outside of the submitted work. The other authors reported no conflict of interest.

Statements on human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Boriani, G., Imberti, J.F., Valenti, A.C. et al. Managing atrial fibrillation: the need for an individualized approach even in the emergency department. Intern Emerg Med 15, 9–12 (2020). https://doi.org/10.1007/s11739-019-02260-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-019-02260-8

Search

Navigation